ACT for CP Individual Patient Expanded Access IND Protocol
Autologous Cell Therapies for Cerebral Palsy-Chronic (ACT for CP) Individual Patient Expanded Access IND Protocol
1 other identifier
expanded_access
N/A
1 country
1
Brief Summary
Individual patient expanded access protocol for a child with cerebral palsy (CP) who has autologous umbilical cord blood available and who is ineligible to participate in other stem cell studies for children with CP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 22, 2017
CompletedFirst Posted
Study publicly available on registry
June 29, 2017
CompletedMay 13, 2020
May 1, 2020
June 22, 2017
May 12, 2020
Conditions
Keywords
Interventions
This is an individual patient expanded access protocol.
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Charles Coxlead
Study Sites (1)
The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Charles S Cox, MD
UTHealth, McGovern Medical School at Houston
Study Design
- Study Type
- expanded access
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- The George and Cynthia Mitchell Distinguished Chair in Neurosciences Director, Children's Program in Regenerative Medicine Professor, Department of Pediatric Surgery UTHealth McGovern Medical School at Houston
Study Record Dates
First Submitted
June 22, 2017
First Posted
June 29, 2017
Last Updated
May 13, 2020
Record last verified: 2020-05